Biochemical markers as a response guide for steroid therapy in asthma

Journal of Asthma

Volumn 45, Issue 5, 2008, Pages 425-428

  Al Obaidi, Amina Hamed ^a   Samarai, Abdulghani Mohamad Al ^a  

^a TIKRIT UNIVERSITY   (Iraq)

Author keywords

Asthma; Biochemical markers; Poorly controlled asthma; Steroid resistant asthma

Indexed keywords

ANTIOXIDANT; BECLOMETASONE DIPROPIONATE; BIOCHEMICAL MARKER; HYDROGEN PEROXIDE; MALONALDEHYDE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPIRED AIR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEROXIDATION; PH; STEROID THERAPY; VENOUS BLOOD;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ALBUTEROL; ASTHMA; BECLOMETHASONE; BIOLOGICAL MARKERS; BREATH TESTS; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 45849142621     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900801956389     Document Type: Article

References (38)

1. Vaughan J, Ngamtrakulpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003; 22:889-894.
2. Moeller A, Kielbasa B. Exhaled breath condensate and other markers in exhaled air. Prog Respir Res 2005; 33:190-202.
3. Emelyanov A, Fedoseev G, Abulimity A, et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001; 120:1136-1139.
4. Al Obaidi AH. Validity assessment of different biochemical markers in asthma. Ph D Thesis , Tikrit University College of Medicine, 2006.
5. Kostikas K, Papatheodorou G, Ganas K, et al. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002;165:1364-1370.
6. Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000;161:694-699.
7. Loukides Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas N. The relationship among hydrogen peroxide in expired breath condensate, airway inflammation and asthma severity. Chest 2002;121:338-346.
8. Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable? Eur Respir J 2004;23:183-184.
9. Barnes PJ. Molecular basis for corticosteroid action in asthma. Chem Immunol 2000;78:72-80.
10. Jatakanon A, Karitonovo S, Lim S, et al. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999;54:108-114.
11. NHLBI /WHO workshop report 2. Global strategy for asthma management and prevention. Bethesda, National Institutes of Health. National Heart, Lung and Blood Institute, 1997; Publication 97-4051A.
12. Gallati H, Pracht I. Horseradish peroxidase: kinetic studies and optimumization of peroxidase activity determination using substrate H2O2 and tetramethyl benzidine. J Clin Chem Clin Biochem 1985;23:453-460.
13. Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indicies of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med 1990;9:515-540.
14. Kampa M, Nistikaki A, Tsaousis V, et al. A new automated method for the determination of the total antioxidant capacity of human plasma, based on crocin bleaching assay. BMC Clin Pathol 2002;2:3-21.
15. Barnes PJ, Greening AP, Crompton GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995;181:33-40.
16. Szefler SJ, Leung DY. Glucocorticoid resistant asthma: pathogenesis and clinical implications for management. Eur respire J 1997;10:1640-1647.
17. Barnes PJ, Woolcock AJ. Difficult asthma. Eur respire J 1998;12:1209-1218.
18. Adcock IM, Brown CR, Shirasaki H, Barnes PJ. Effects of dexamethasone on cytokine and phorbol ester stimulated c- Fos and c- Jun DNA binding and gene expression in human lung. Eur Respir J 1994;7:2117-2123.
19. Adcock IM, Lane SJ, Brown CA, Lee TH, Barnes PJ. Abnormal glucocorticoids receptor / AP-1 interaction in steroid resistant asthma. J Exp Med 1995;182:1951-1958.
20. Adcock IM, Brady H, Lim S, Karin M, Barnes PJ. Increased JUN kinase activity in peripheral blood monocyte from steroid resistant asthmatic subjects. Am J Respir Crit Care Med 1997;155: A288.
21. Barnes PJ, Adcock IM. Steroid resistant asthma. Q J Med 1995;88:455-468.
22. Cypcar D, Busse WW. Steroid resistant asthma. J Allergy Clin Immunol 1993;92:362-372.
23. Lane SJ, Atkinson BA, Swimmanthan R, Lee TH. Hypothalamic - pituitary axis in corticosteroid resistant asthma. Am J Respir Crit Care Med 1996;153:1510-1514.
24. Panettieri RA. Effect of corticosteroid on structural cells in asthma and COPD. Proceeding ATS 2004;1:231-234.
25. Stewart RM, Weir EK, Montgomery MR, Niewoehner DE. Hydrogen peroxide contracts airway smooth muscle: a possible endogenous mechanism. Respir Physiol 1981;45:333-342.
26. Rhoden KJ, Barnes PJ. Effect of hydrogen peroxide on guinea pig tracheal muscle in vitro: role of cyclooxygenase and airway epithelium. Br J Pharmacol 1989;98:325-330.
27. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997;10: 1235-1241.
28. Synek M, Beasley R, Frew AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996;154:224-230.
29. Vrugt B, Djukanovic R, Bron A, Aalbers R. New insights into the pathogenesis of severe corticosteroid - dependent asthma. J Allergy Clin Immunol 1996;98:S22-S26.
30. Wenzel SE, Szefler SJ, Leung DY, et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
31. Jatakanon A, Mohamad JB, Lim S, et al. Neutrophils may contribute to the pathogenesis of airway inflammation in steroid - dependent intractable asthma. Am J respire Crit Care Med 1998;157:A875.
32. Jonat C, Rahsdorf HJ, Park KK, et al. Anti tumor promotion and ant inflammation: down modulation of AP-1 activity by glucocorticoids hormone. Cell 1990;62:1189-1204.
33. Yang - Yen H, Chambard J, Sun Y, et al. Transcriptional interference between c- Jun and the glucocorticoids receptor: mutual inhibition of DNA binding due to direct protein interaction. Cell 1990;62: 1205-1215.
34. 2 agonist dose reduction: strategy and early results. Thorax 1993;48:1066.
35. Sears MR. Dose reduction of beta agonists in asthma. Lancet 1991;338:1331-1332.
36. Nijkamp FP, Henricks PA. Receptors in airway disease. Beta- adrenoreceptors in lung inflammation. Am Rev Respir Dis 1990; 141 (supplement):S145-150.
37. Katsumata μ, Miura M, Ichinose M, et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990;141:1158-1161.
38. Abe MK, Chao TS, Solway J, Rosner MR, Hershenson MB. Hydrogen peroxide stimulates mitogen activated protein kinase in bovine tracheal myocytes : implications for human airway disease. Am J Respir Cell Mol Biol 1994;11:577-585.